Mass General Brigham, Inc
- SEC CIK
- 0001678378
- Latest filing
- Aug 7, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed Apr 4, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 5
- +3 vs. Q4 2023
- Portfolio value
- $57.1M
- +$29.1M (+103.9%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| COINCoinbase Global, Inc. | COM CL A | 140,229 | $37.2M | 65.1% | +11,282+8.7% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 338,191 | $10.9M | 19.1% | +338,191 | New | History |
| PLRXPliant Therapeutics, Inc. | COM | 288,690 | $4.30M | 7.5% | +288,690 | New | History |
| TNGXTango Therapeutics, Inc. | COM | 354,192 | $2.81M | 4.9% | +354,192 | New | History |
| FULCFulcrum Therapeutics, Inc. | COM | 205,356 | $1.94M | 3.4% | +205,356 | New | History |
Sold out since Q4 2023 (1)
Positions held at the end of Q4 2023 that are gone from this filing.